Identifying and Integrating Predictive Factors for Mandibular Osteoradionecrosis after Irradiation of Head and Neck Cancers.

Abstract Testing for various risk factors for mandibular osteoradionecrosis (ORN) should be performed before and after treatment in patients with head and neck cancer. The different clinical criteria for this severe radiation-induced complication are patient-dependent (intrinsic radiosensitivity, undernutrition due to weight loss, smoking, microcapillary involvement, unstable oral status, hyposalivation) and/or disease-related (oral cancer). The risk factors are also related to the disease (e.g., advanced tumor size, mandibular tumor invasion). Therapeutic risk factors are also associated with a higher risk of ORN (primary tumor surgery, chemotherapy with radiotherapy, tooth extraction after radiotherapy, stomatological follow-up and daily fluoride groove placement, non-observance of prophylaxis in case of absence, and non-observance of curative treatment). Finally, various dose studies have specified parameters targeting dose levels delivered to the mandible that increased the risk of ORN. Mean mandibular doses above 48-54 Gy and a high proportion of mandibular volumes receiving 30-60 Gy appear to discriminate against the risk of developing ORN. Key word: Head and neck cancers – Mandibular osteoradionecrosis – Predictive factors – Dosimetric parameters

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-11-01
DOI
https://doi.org/10.5281/zenodo.14159986
Primary Topic
Oral health in cancer treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identifying and Integrating Predictive Factors for Mandibular Osteoradionecrosis after Irradiation of Head and Neck Cancers.

Zenodo (CERN European Organization for Nuclear Research)
Oral health in cancer treatment
article

Identifying and Integrating Predictive Factors for Mandibular Osteoradionecrosis after Irradiation of Head and Neck Cancers.

article en

Abstract

Abstract Testing for various risk factors for mandibular osteoradionecrosis (ORN) should be performed before and after treatment in patients with head and neck cancer. The different clinical criteria for this severe radiation-induced complication are patient-dependent (intrinsic radiosensitivity, undernutrition due to weight loss, smoking, microcapillary involvement, unstable oral status, hyposalivation) and/or disease-related (oral cancer). The risk factors are also related to the disease (e.g., advanced tumor size, mandibular tumor invasion). Therapeutic risk factors are also associated with a higher risk of ORN (primary tumor surgery, chemotherapy with radiotherapy, tooth extraction after radiotherapy, stomatological follow-up and daily fluoride groove placement, non-observance of prophylaxis in case of absence, and non-observance of curative treatment). Finally, various dose studies have specified parameters targeting dose levels delivered to the mandible that increased the risk of ORN. Mean mandibular doses above 48-54 Gy and a high proportion of mandibular volumes receiving 30-60 Gy appear to discriminate against the risk of developing ORN. Key word: Head and neck cancers – Mandibular osteoradionecrosis – Predictive factors – Dosimetric parameters

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 53%
Oral health in cancer treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Identifying and Integrating Predictive Factors for Mandibular Osteoradionecrosis after Irradiation of Head and Neck Cancers. · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS